Saba Capital Management’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Saba Capital Management’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,631,601	Closed	-$16.5M	–	1015
2022 Q3	$16.5M	Buy	1,631,601 +250,000	+18%	+$2.52M	0.19%	158
2022 Q2	$13.9M	Buy	1,381,601 +89,013	+7%	+$894K	0.16%	204
2022 Q1	$12.9M	Buy	1,292,588 +159,393	+14%	+$1.59M	0.18%	164
2021 Q4	$11.3M	Buy	+1,133,195	New	+$11.2M	0.17%	154

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Saba Capital Management's ARCK Position: Q4 2022 in Review

Saba Capital Management sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 1,631,601 shares — an estimated $16.5M sold.

Saba Capital Management first reported a position in ARCK in Q4 2021 and held it in 4 quarters. The position peaked at $16.5M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Saba Capital Management reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Saba Capital Management sold 1,631,601 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $16.5M.
Saba Capital Management first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q4 2021 and held it in 4 quarters.
Saba Capital Management's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $16.5M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Saba Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.